Showing results (1731-1740 of 2,037) with videos related to
Sort By:
Pageof 204
Nuklearmedizin. Nuclear Medicine|October 1, 1978
Assessment of regional wall motion in coronary artery disease using radionuclide methodsE Ogris, O Pachinger, H Sochor, et al.Nuklearmedizin. Nuclear Medicine|May 20, 2015
Lowest effective 131I activity for thyroid remnant ablation of differentiated thyroid cancer patients. Dosimetry-based model for estimationW Jentzen, A-S Moldovan, M Ruhlmann, et al.Nuklearmedizin. Nuclear Medicine|August 1, 1997
Tc-99m DTPA perfusion scintigraphy and color coded duplex sonography in the evaluation of minimal renal allograft perfusionH J Bair, E Günter, H Rupprecht, et al.Nuklearmedizin. Nuclear Medicine|October 10, 1997
Myocardial perfusion and metabolism after transcoronary ablation of septum hypertrophy (TASH) in hypertrophic obstructive cardiomyopathyH Lerch, M Schäfers, F Gietzen, et al.Nuklearmedizin. Nuclear Medicine|January 24, 1998
[18F-fluorodeoxyglucose PET in ovarian carcinoma: methodology and preliminary results]M Zimny, W Schröder, S Wolters, et al.Nuklearmedizin. Nuclear Medicine|December 1, 1986
Specific imaging of human brain tumor xenografts utilizing radiolabelled monoclonal antibodies (MAbs)D E Bullard, C J Wikstrand, P A Humphrey, et al.Nuklearmedizin. Nuclear Medicine|December 1, 1986
Limitations in localising and killing tumours using radiolabelled antibodiesA R Bradwell, A T Vaughan, P W DykesNuklearmedizin. Nuclear Medicine|October 1, 1986
[Serum thyroglobulin in the diagnosis of metastases of differentiated thyroid cancer. Effect of suppressive thyroid hormone substitution on the diagnostic accuracy of thyroglobulin values]H W Müller-Gärtner, C Schneider, M T TempelNuklearmedizin. Nuclear Medicine|October 1, 1986
[Iodine-induced T3 hyperthyroidism in metastatic follicular thyroid cancer]C Ehrenheim, P Heintz, O Schober, et al.Pageof 204